SeerPharma UK recently completed the first phase of a high-impact project for a global leader in temperature-controlled life sciences distribution. Working alongside key personnel across international sites, we provided the technical framework necessary to secure the integrity of highly sensitive pharmaceutical supply chains.

The Challenge

Operating in a temperature-critical sector requires more than just high-spec equipment; it demands a rigorous, documented assurance that every component of the cold chain functions perfectly. The client needed a unified strategy to manage a wide range of equipment across global locations while ensuring compliance with stringent GDP/GMP requirements.

The Solution

Our consultants delivered deep technical expertise to standardise the client’s validation infrastructure. The first phase focused on:

• Strategic Documentation: Developing a robust Validation Master Plan (VMP) and detailed User Requirement Specifications (URS) for complex, temperature-critical assets.
• Risk-Based Methodology: Implementing a targeted approach to identify Critical Control Points (CCPs) within the distribution process, ensuring resources are focused where they impact product quality most.
• Continued Process Verification (CPV): Applying CPV principles to provide documented evidence that the validated state is maintained throughout the equipment lifecycle, rather than just at a single point in time.

The Outcome

This collaborative engagement has not only strengthened the client’s technical documentation but also upskilled their internal teams. As the project moves into its second phase—rolling out this standardised approach globally—the company benefits from a consistent, audit-ready framework that ensures patient safety through reliable, temperature-secure distribution and compliance.

More case studies